| Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase–associated lipocalin for diagnosing acute kidney injury TL Nickolas, MJ O'Rourke, J Yang, ME Sise, PA Canetta, N Barasch, ... Annals of internal medicine 148 (11), 810-819, 2008 | 946 | 2008 |
| Diagnostic utility of exome sequencing for kidney disease EE Groopman, M Marasa, S Cameron-Christie, S Petrovski, VS Aggarwal, ... New England Journal of Medicine 380 (2), 142-151, 2019 | 875 | 2019 |
| Rituximab or cyclosporine in the treatment of membranous nephropathy FC Fervenza, GB Appel, SJ Barbour, BH Rovin, RA Lafayette, N Aslam, ... New England Journal of Medicine 381 (1), 36-46, 2019 | 669 | 2019 |
| Kidney biopsy findings in patients with COVID-19 S Kudose, I Batal, D Santoriello, K Xu, J Barasch, Y Peleg, P Canetta, ... Journal of the American Society of Nephrology 31 (9), 1959-1968, 2020 | 501 | 2020 |
| Eculizumab for dense deposit disease and C3 glomerulonephritis AS Bomback, RJ Smith, GR Barile, Y Zhang, EC Heher, L Herlitz, ... Clinical Journal of the American Society of Nephrology 7 (5), 748-756, 2012 | 481 | 2012 |
| Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study TL Nickolas, KM Schmidt-Ott, P Canetta, C Forster, E Singer, M Sise, ... Journal of the American College of Cardiology 59 (3), 246-255, 2012 | 474 | 2012 |
| A randomized, controlled trial of rituximab in IgA nephropathy with proteinuria and renal dysfunction RA Lafayette, PA Canetta, BH Rovin, GB Appel, J Novak, KA Nath, S Sethi, ... Journal of the American Society of Nephrology 28 (4), 1306-1313, 2017 | 346 | 2017 |
| Acute kidney injury due to collapsing glomerulopathy following COVID-19 infection Y Peleg, S Kudose, V D’Agati, E Siddall, S Ahmad, T Nickolas, S Kisselev, ... Kidney international reports 5 (6), 940-945, 2020 | 310 | 2020 |
| Systematic review and meta-analysis of native kidney biopsy complications ED Poggio, RL McClelland, KN Blank, S Hansen, S Bansal, AS Bomback, ... Clinical Journal of the American Society of Nephrology 15 (11), 1595-1602, 2020 | 264 | 2020 |
| Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the … J Barratt, R Lafayette, J Kristensen, A Stone, D Cattran, J Floege, V Tesar, ... Kidney international 103 (2), 391-402, 2023 | 248 | 2023 |
| Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial BH Rovin, J Barratt, HJL Heerspink, CE Alpers, S Bieler, DW Chae, ... The Lancet 402 (10417), 2077-2090, 2023 | 245 | 2023 |
| C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy AS Bomback, D Santoriello, RS Avasare, R Regunathan-Shenk, ... Kidney international 93 (4), 977-985, 2018 | 239 | 2018 |
| Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial HJL Heerspink, J Radhakrishnan, CE Alpers, J Barratt, S Bieler, U Diva, ... The Lancet 401 (10388), 1584-1594, 2023 | 236 | 2023 |
| Whole-exome sequencing in adults with chronic kidney disease: a pilot study S Lata, M Marasa, Y Li, DA Fasel, E Groopman, V Jobanputra, H Rasouly, ... Annals of internal medicine 168 (2), 100-109, 2018 | 232 | 2018 |
| The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis J Xie, L Liu, N Mladkova, Y Li, H Ren, W Wang, Z Cui, L Lin, X Hu, X Yu, ... Nature communications 11 (1), 1600, 2020 | 217 | 2020 |
| Rationale and design of the kidney precision medicine project IH De Boer, CE Alpers, EU Azeloglu, UGJ Balis, JM Barasch, L Barisoni, ... Kidney international 99 (3), 498-510, 2021 | 181 | 2021 |
| Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy K Kiryluk, E Sanchez-Rodriguez, XJ Zhou, F Zanoni, L Liu, N Mladkova, ... Nature genetics 55 (7), 1091-1105, 2023 | 167 | 2023 |
| Interstitial fibrosis scored on whole-slide digital imaging of kidney biopsies is a predictor of outcome in proteinuric glomerulopathies LH Mariani, S Martini, L Barisoni, PA Canetta, JP Troost, JB Hodgin, ... Nephrology Dialysis Transplantation 33 (2), 310-318, 2018 | 130 | 2018 |
| CureGN study rationale, design, and methods: establishing a large prospective observational study of glomerular disease LH Mariani, AS Bomback, PA Canetta, MF Flessner, M Helmuth, ... American journal of kidney diseases 73 (2), 218-229, 2019 | 128 | 2019 |
| Mycophenolate mofetil in combination with steroids for treatment of C3 glomerulopathy: a case series RS Avasare, PA Canetta, AS Bomback, M Marasa, Y Caliskan, Y Ozluk, ... Clinical Journal of the American Society of Nephrology 13 (3), 406-413, 2018 | 121 | 2018 |
